ACTIVE_NOT_RECRUITING

Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.

Official Title

Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

Quick Facts

Study Start:2023-11-13
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05700994

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 105 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
  2. * Are willing to be trained in the two strategies for peer-facilitated contingency management
  3. * Age 18 and older
  4. * Any stimulant (methamphetamine, cocaine) use in the past 30 days
  5. * Willing to accept peer services
  6. * Willing to complete initial and follow-up assessments with peer
  7. * Able to communicate in English or Spanish
  1. * Do not use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
  2. * Are not willing to be trained in the two strategies for peer-facilitated contingency management

Contacts and Locations

Study Locations (Sites)

Comagine Health
Portland, Oregon, 97232
United States
Oregon Health & Science University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-13
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2023-11-13
Study Completion Date2026-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Methamphetamine Abuse